NTRK1 and neoplasm: In a final experimental setup, effects of the pan-Trk inhibitor entrectinib were also tested in KM12 tumor-bearing mice pre-treated with 15 mg/kg amitriptyline before to analyze if there would be still a functional blocking effect in peripheral tissue.